Singaporean Capital Markets Stock News

SGX:9CI
SGX:9CIReal Estate

CapitaLand Investment (SGX:9CI) Valuation Check After FY2025 Earnings And New Asia Subsidiaries

Earnings and new subsidiaries set the tone for CapitaLand Investment (SGX:9CI) CapitaLand Investment (SGX:9CI) has been in focus after its full year 2025 earnings showed sales of S$2,133 million and net income of S$145 million, along with wide ranging subsidiary incorporations across Asia. See our latest analysis for CapitaLand Investment. The earnings release and new subsidiaries land against a backdrop of a 16.9% 90 day share price return and a 33.4% 1 year total shareholder return. By...
SGX:A04
SGX:A04Machinery

ASL Marine Holdings (SGX:A04) One Off Gain Clouds Strong Margin Narrative In H1 2026

ASL Marine Holdings (SGX:A04) has reported a busy set of numbers for H1 2026, with total revenue of S$177.9 million and basic EPS of S$0.0133, alongside trailing twelve month revenue of S$359.5 million and EPS of S$0.0297. The company has seen revenue move from S$170.6 million in H2 2024 to S$172.2 million in H1 2025 and then to S$177.9 million in H2 2025. Over the same halves, net income (excluding extra items) went from S$2.4 million to S$1.5 million and then to S$13.1 million. This sets up...
SGX:HQU
SGX:HQUConstruction

Oiltek International (SGX:HQU) Margin Strength At 15.1% Tests Bullish Growth Narratives

Oiltek International (SGX:HQU) has posted its FY 2025 numbers with second half revenue of MYR 110.6 million and basic EPS of MYR 0.0416, alongside trailing twelve month revenue of MYR 211.4 million and EPS of MYR 0.0745 that reflect the business it has built over the past year. The company has seen revenue move from MYR 129.8 million in 2H FY 2024 to MYR 110.6 million in 2H FY 2025, with net income shifting from MYR 19.4 million to MYR 17.8 million over the same periods, setting the backdrop...
SGX:A50
SGX:A50Healthcare

Thomson Medical Group (SGX:A50) Loss Narrows In H1 2026 Challenging Bearish Profitability Narratives

Thomson Medical Group (SGX:A50) has posted its H1 2026 numbers with revenue of S$215.9 million and a net loss of S$10.2 million, translating to basic EPS of S$0.000386 loss. The company’s revenue increased from S$201.9 million in H1 2025 to S$215.9 million in H1 2026, while basic EPS improved from a S$0.000487 loss to a S$0.000386 loss. This sets the stage for investors to focus on how quickly margins can recover from the current loss making position. See our full analysis for Thomson Medical...
SGX:W05
SGX:W05Real Estate

Wing Tai Holdings (SGX:W05) Return To Profit Tests Bearish Earnings Narratives

Wing Tai Holdings (SGX:W05) posts higher H1 revenue with a return to profit Wing Tai Holdings (SGX:W05) has put out a cleaner set of numbers for H1 2026, with revenue at S$270.2 million and basic EPS of S$0.0528, setting a very different tone to the loss making run shown in the trailing figures. The company has seen revenue move from S$112.7 million in H1 2025 to S$270.2 million in H1 2026, while basic EPS shifted from S$0.0132 to S$0.0528 over the same period, giving investors a fresh read...
SGX:D05
SGX:D05Banks

Assessing DBS Group Holdings (SGX:D05) After Strong 1‑Year Rally And Regulatory Focus

If you are wondering whether DBS Group Holdings is offering fair value at today’s price, you are not alone. This article will walk through what the current market price might be implying. With the share price at S$58.19 and returns of 3.2% year to date and 36.0% over the past year, DBS has been on many investors’ watchlists. This is despite a 1.2% decline over the last 7 days and a more modest 1.0% return over the past month. Recent news around DBS has largely focused on its position as a...